Pharmaceutical Market in India (Category-Large Scale Enterprise ,Medium Scale Enterprise and Small Scale Enterprise) Industry Analysis, Volume, Share, Growth,Challenges, Trends, and Forecast 2016 – 2025.

Select Licence Type

• Single User : $3000 ‎
• Multi User : $4500
• Corporate User : $6000

Report Description

Overview

India Pharmaceutical Market ranks 3rd in terms of Volume and 14 th in terms of Revenue globally. India is the only country in the world which has a clear distinction between Pharmaceutical and Biotech industry. India Pharmaceutical Market is the largest provider of generic drugs globally with the Indian generics accounting for 20 % of global exports in terms of volume. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.

Indian Pharmaceutical Market has two main category based on production level Large scale enterprises and Small and Medium enterprise (SME). Large scale enterprises holds around 70 % of the market. Large scale Pharma industry comprises of nearly 250 leading drug producer in India.

The Indian Pharmaceutical Market, which is expected to grow over 15 % per annum between 2015 and 2020, will outperform the global pharma industry, which is set to grow at an annual rate of 5 per cent between the same period. India has also maintained its lead over China in pharmaceutical exports with a year-on-year growth of 11.44 per cent to US$ 12.91 billion in FY 2015-16.

Pharmaceutical Market : Segment Analysis

• Large scale enterprises
• Medium scale enterprises
• Small scale enterprises

Pharmaceutical Market : Export Analysis By Region

Indian Pharmaceutical Market has exported USD 13.7 billion worth of Pharmaceutical products in FY 2016-17. India has also maintained its lead over China in pharmaceutical exports with a year-on-year growth of 11.44 per cent to US$ 12.91 billion in FY 2015-16. It is estimated that around 40 % of the generic drugs in the US come from India. The 10 countries below imported 56.5 % of that total.

• North America
  • U.S.
• Europe
  • UK
  • Germany
  • Russia
• Australia
• Latin America
  • Brazil
• Middle East and Africa
  • Tanzania
  • South Africa
  • Kenya
  • Nigeria